CLINICAL TRIALS PROFILE FOR TRANXENE SD
✉ Email this page to a colleague
All Clinical Trials for TRANXENE SD
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00775996 ↗ | Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2003-08-01 | The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions. |
NCT02323659 ↗ | Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas | Unknown status | Polish Lymphoma Research Group | Phase 4 | 2014-06-01 | Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety and quality of life in patients with primary cutaneous T-cell lymphomas after failure of topical or phototherapy treatment. |
NCT04726592 ↗ | Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room | Recruiting | Assistance Publique - Hôpitaux de Paris | Phase 3 | 2021-07-08 | The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRANXENE SD
Condition Name
Clinical Trial Locations for TRANXENE SD
Trials by Country
Clinical Trial Progress for TRANXENE SD
Clinical Trial Phase
Clinical Trial Sponsors for TRANXENE SD
Sponsor Name